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 Abstract  
Introduction: This study aimed to establish the reliability and validity of the Primary 
Health Questionnaire Somatic Symptom Severity Subscale (PHQ-15) for postpartum 
women. 
Methods: Women (N = 495) completed the PHQ-15 approximately six weeks 
postpartum during the baseline phase of a randomised controlled trial evaluating a 
writing intervention for postnatal health in England. Reliability was assessed using 
internal consistency statistics and convergent validity by comparing differences in 
self-reported physical health, health-related quality of life (QoL), and primary care 
usage by PHQ-15 symptom severity category. 
Results:  Cronbach’s Į for the PHQ-15 was 0.73 and item-total statistics met 
recommended guidelines. Validity analyses showed 6% of women reported severe 
symptoms, 17% medium, 50% low, and 27% minimal symptoms. Women with severe 
symptoms reported poorer overall physical health, poorer physical health-related 
QoL, and greater use of primary care. Women with severe symptoms also rated their 
baby’s health as worse and used primary care more for their baby. 
Discussion:  This study suggests the PHQ-15 has the potential to be a useful and valid 
measure of physical symptoms in postpartum women in high-income countries.  
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 Introduction 
Pregnancy, birth and the postpartum period involve huge physiological changes and 
women often experience normal and abnormal physical symptoms during this time [1-
4] with over 90% of women reporting physical health problems after birth [2, 5]. 
There is substantial evidence from other populations that physical symptoms are 
associated with psychological symptoms [6]. Less research has been done with 
women during pregnancy and postpartum but the findings are consistent with the 
broader literature, showing physical symptoms can be associated with psychological 
problems such as depression, anxiety or somatic disorders [3, 4]. For example, a 
longitudinal study of women in pregnancy found that physical symptoms in the 
second trimester of pregnancy predicted symptoms of depression in the last trimester 
[7].  Similarly, a population study of 78,660 women in Norway found that women 
with a previous and recent history of sexual violence were approximately seven times 
more likely to suffer from eight or more physical symptoms in pregnancy [8].  High 
levels of physical symptoms during pregnancy and after birth are therefore associated 
with poor emotional and physical wellbeing in women.  
Women’s physical symptoms in pregnancy and after birth may also affect the 
baby. Women’s physical wellbeing during pregnancy can affect the developing fetus 
[9]. Severe symptoms associated with health anxiety or somatic disorders may also 
heighten women’s concerns about their own and/or their baby’s health.  It is therefore 
important to examine physical symptoms in pregnancy and after birth for a number of 
reasons.  These include being able to discern normal from abnormal physical 
symptoms, identifying women with a high number of physical symptoms who may be 
at greater risk of psychological problems, or as a potential marker of sexual abuse.  
 The current study focused on measuring physical symptoms during the 
postpartum period. The way in which physical symptoms are measured at this time is 
important.  Various measures of physical symptoms are available but few are 
validated for use in postpartum samples. One measure of physical symptoms is the 
Primary Health Questionnaire Somatic Symptom Subscale (PHQ-15) [10].  The PHQ-
15 was originally designed to assess “15 somatic symptoms or symptom clusters most 
prevalent in somatization disorder” and was initially validated in both primary care 
and obstetric-gynecology clinical settings (p. 259) [10].  Initial results indicated 
symptom severity as measured by the PHQ-15 was linked to lower functional health 
and both increased healthcare usage and disability days.  The PHQ-15 has a number 
of advantages in that it is widely used [11-13], is considered reliable and valid for 
general [14, 15] and clinical populations [11, 16-18], has been translated into several 
languages [12-15, 17, 18], and has been widely implemented in healthcare.  It also 
includes items that assess the severity of the most common symptoms in postpartum 
women including tiredness and musculoskeletal problems [3, 5], as well as symptoms 
associated with poor self-rated health such as headache, stomach pain, nausea and 
musculoskeletal problems [19].    
In the original PHQ-15 validation study [10], the obstetric-gynecology sample 
was not disaggregated so evidence of its reliability and validity for postpartum 
women specifically was not established.  Whilst subsequent studies have confirmed 
the suitability of the PHQ-15 in other clinical populations [11, 16-18], evidence of the 
reliability and convergent validity of the PHQ-15 for use with postpartum women still 
needs to be confirmed as “symptoms can result from normal physiological changes in 
pregnancy and the early post-partum period, so therefore need to be assessed with 
care.” (p. 384) [20]. To our knowledge, only one prior study used the PHQ-15 with a 
 perinatal sample and this was in a low-income country “where the burden of under-
nutrition and infectious disease morbidity is high (p. 340)” [21].  In that study, a 
modified version of the PHQ-15 was implemented which: 1) eliminated two items 
regarding feeling tired/having low energy and problems sleeping based on an overlap 
with another study measure, and 2) modified item wording regarding menstruation to 
vaginal discharge.  This study found the PHQ-15 predicted poorer daily functioning 
[21], providing initial evidence of suitability for use with perinatal women. However, 
the generalizability of these findings are limited to women in low-income countries 
when using a modified version of the PHQ-15.  
The aim of the present study was therefore to examine whether evidence for 
the reliability and convergent validity of the standard PHQ-15 exists for a postpartum 
sample from a high-income country.  Evidence of reliability was explored using 
internal consistency statistics chosen to facilitate comparison with values reported in 
prior studies.   Evidence of convergent validity was established by examining 
differences between women with minimal, low, medium and high levels of physical 
symptoms in self-rated physical health, physical and mental health related quality of 
life (QoL), and primary care usage. In addition, differences in women’s ratings of 
their babies’ physical health and primary care usage were examined.  The following 
hypotheses were tested: 
 
HY1:  The internal consistency statistics for the PHQ-15 in this postpartum 
sample from a high-income country will be similar to values reported in other 
populations. 
HY2:  Compared with women in other severity groups, women high in PHQ-
15 symptom severity will:  
 HY2A:  rate their physical health lower,  
HY2B:  report lower health-related quality of life, and  
HY2C:  report greater primary care use.  
HY3:  Compared with women in other severity groups, women high in PHQ-
15 symptom severity will: 
HY3A:  rate their baby’s physical health lower and  
HY3B:  report greater primary care use for the baby.    
Methods 
Design 
This study examines evidence for the reliability and convergent validity of the PHQ-
15 with postpartum women based on a secondary analysis of data collected as part of 
a randomised controlled trial evaluating a writing intervention for improving 
women’s postnatal health [REF removed for blind review].  Data presented here are 
from the baseline measures completed prior to intervention, at approximately six to 
eight weeks postpartum.  
Procedure 
The project was approved by an NHS Research Ethics Committee. Participants were 
recruited from 11 acute NHS hospital trusts in England between November 2013 and 
December 2014.  All were aged 18 years or older and had given birth to a live infant 
after 26 weeks gestation. All eligible women (N = 7986) in the 11 NHS Trusts were 
sent a letter inviting them to take part approximately four weeks after birth.  Of these, 
1413 replied and 854 consented to participate.  The majority of women who declined 
to participate reported they were too busy (n = 422). A further four women were 
excluded because their contact details could not be obtained.  A number of women 
who initially consented to participate did not complete any baseline measures; the 
 final sample for analysis of baseline measures including the PHQ-15 was 548. 
Women completed baseline measures by post or online. Participants also provided 
socio-demographic information. Obstetric information was obtained from medical 
records.  There were no incentives for participation.  A detailed account of the design 
and procedure for the primary study can be found in the study protocol [REF removed 
for blind review]. 
Sample  
Table 1 summarizes mothers’ socio-demographic and obstetric characteristics. Most 
women were white European, educated to degree level or higher, employed, and 
married/living with partner. Approximately 19% reported having been diagnosed with 
or treated for psychological problems at some point before their baby was born; 36 
women (7.3%) reported having been diagnosed or treated since giving birth. Gestation 
was 37 weeks or more for 86% of the sample.  Approximately half were multiparous 
(52%), had normal vaginal births (55%), and experienced maternal and/or neonatal 
complications (53%).   
Study measures 
Physical health questionnaire somatic symptom subscale (PHQ-15) 
The standard English version of the PHQ-15 [10] was used. Participants rated the 
severity of 15 symptoms experienced over the last four weeks as 0 (not bothered at 
all), 1 (bothered a little), or 2 (bothered a lot).  PHQ-15 scores can range from 0–30. 
Symptom severity was categorized as minimal (0–4), low (5–9), medium (10-14), or 
high (15 +) [10].  
Convergent validity measures 
As evidence of convergent validity of the PHQ-15, three outcomes were expected to 
vary based on symptom severity. These were women’s self-rated overall physical 
 health, health-related quality of life (QoL), and primary care usage. In addition, 
women’s ratings of their baby’s health and primary care usage were also expected to 
differ.  Convergent validity outcomes were operationally defined as follows:  
Overall physical health was rated by participants on a single item covering the most 
recent four weeks using a 10-point Likert scale (1 = extremely bad; 10 = best possible 
health). An identical single item was used to obtain the mother’s perception of their 
baby’s physical health. 
Health-related quality of life was measured using the SF-12v2 health survey, a 
reliable and valid 12-item self-report measure of QoL over the prior four weeks [22].  
Response options varied across items.  Women rated their overall general health with 
a 5-point Likert scale (1 = excellent; 5 = poor).  Five items were rated using Likert 
scales with lower values indicating poorer outcomes.  For example, the impact of 
bodily pain was measured by: ‘During the past four weeks, how much did pain 
interfere with your normal work including both outside the home and housework?’ (1 
= extremely; 5 = not at all).  Two items assessed the ability to conduct moderate 
activities (vacuuming, climbing stairs) using a 3-point scale (1 = yes, limited a lot; 3 = 
No, not limited at all).   Four items had yes/no response options to further assess 
limitations due to physical health and emotional problems (During the past four 
weeks, did you accomplish less than you would like as a result of an emotional 
problem, such as feeling depressed or anxious?).   Quality Metric Incorporated 
calculated physical and mental component scores based on weighted, combined item 
scores using its proprietary SF-12v2 software.  Component scores range from 0 to 100 
with higher values indicating better QoL. The normative mean for both components is 
50 (SD =10). 
 Primary care usage was measured as the number of visits for themselves to primary 
care or other healthcare professionals in a primary care setting for any reason with 
routine maternity care appointments excluded.  A similar item was used to measure 
primary care usage for their baby. 
Statistical analysis 
Full PHQ-15 data were obtained from 482 women; 66 women had missing data. Of 
these 66 participants, 13 had only a single missing value that varied across items. 
Median imputation was used for these values and the women were included in the 
final analysis (N = 495). The remaining 53 had missing data percentages considered 
inappropriate for statistical imputation [23].  Descriptive statistics were calculated for 
participants’ socio-demographic and obstetric characteristics, PHQ-15 items, and 
convergent validity outcomes. PHQ-15 reliability was assessed using internal 
consistency statistics (Cronbach’s Į, Įif item deleted, corrected item-total 
correlations).  These internal-consistency statistics were chosen to facilitate 
comparison of the evidence from the current study with prior studies.  One-way 
analyses of variance compared convergent validity outcomes by PHQ-15 symptom 
severity category with Bonferroni adjustment implemented for post-hoc analyses. 
SPSS version 23.0 was used for all analyses. 
Results 
Evidence of reliability 
Internal consistency statistics are presented in Table 2. Cronbach’s Įfor the PHQ-15 
was 0.73; a value of 0.70 is considered satisfactory for group comparison [24].   
Values for women reported in other studies ranged from 0.73 in a general sample of 
women [15, 18], 0.77 with young women [11], and 0.80 in the original obstetric-
gynecology sample [10]. Removing items did not improve Cronbach’s alpha. The 
 average item-total correlation (0.33) and corrected item-total correlations (0.21 – 
0.46) were within the recommended guidelines of a minimum of 0.15 – 0.20 and 0.15 
– 0.50 respectively [25, 26]. 
Evidence of convergent validity 
Table 3 provides the correlations between the PHQ-15 and the outcomes for mother 
and baby.  Table 4 shows the differences in overall physical health, health-related 
QoL, and primary care usage for mother and baby by PHQ-15 symptom severity 
category. In this sample, 136 women (27%) were categorized as minimal, 247 (50%) 
as low, 83 (17%) as medium, and 29 (6%) as high in symptom severity. 
Mother’s perceived physical health, health-related quality of life and primary care 
usage 
Somatic symptom severity as measured by the PHQ-15 total score was significantly, 
negatively correlated with overall physical health rating and physical health-related 
QoL; and was significantly, positively associated with primary care usage by the 
mother.  The relationship between somatic symptom severity and mental health-
related QoL was not significant (p = .16). 
Physical health ratings differed by PHQ-15 symptom severity category. 
Women categorized as minimal or low severity rated their own physical health higher 
than either medium or high severity groups (Welch’s F (3, 105.61) = 19.09, p < .001, 
Ș2p = .13). Physical health-related QoL also differed significantly by symptom 
severity category (Welch’s F (3, 105.04) = 31.93, p Ș2p = .17). Women 
categorized as either medium or high severity rated their physical health-related QoL 
lower than those with minimal or low symptoms. The mean rating by participants 
from the medium/high severity categories was approximately equal to the normed 
mean (50); those in the minimal/low severity category had mean ratings above the 
 normed mean (+1.0 SD and +0.6 SD respectively).  Mental health-related QoL did not 
differ by symptom severity category (Welch’s F (3, 105.68) = 0.04, p  Ș2p = 
.00).   
Primary care usage differed significantly by PHQ symptom severity category 
(Welch’s F (3, 102.01) = 6.79, p Ș2p = .04). Women with high severity 
reported more primary care visits for themselves than the minimal and low groups; 
visits by those in the medium severity category did not differ statistically from any 
other group. 
Mother’s ratings of baby’s physical health and primary care usage 
Mother’s PHQ-15 total score was significantly, negatively correlated with ratings of 
the baby’s overall physical health and positively associated with primary care usage 
for the baby.  The entire sample rated their baby’s overall physical health highly; but 
a main effect of symptom severity category indicated women with high symptom 
severity rated their baby’s health lower than women in all other categories (Welch’s F 
(3, 105.90) = 2.80, p < .05Ș2p = .03).  Participants with high symptom severity also 
reported more primary care usage for their baby than participants in all other 
categories (Welch’s F (3, 99.31) = 3.11, p Ș2p = .04). 
Discussion 
This study aimed to determine the reliability and convergent validity of the PHQ-15 
in postpartum women from a high-income country. The results provide evidence of 
the reliability and validity of the PHQ-15 for use with postpartum women. Internal 
consistency of the PHQ-15 was 0.73, a value consistent with those previously 
reported for women [15, 18]. Corrected item-total correlations also indicated that all 
items exceeded established minimum criterion [25, 26].  Based on PHQ-15 scores, 
approximately 6% of women were classified as having high symptom severity. This is 
 a similar percentage to that reported in 18-34 year old women in Sweden [15] but less 
than the 9% reported in the obstetrics/gynecology validity study [10] or 14% in a 
gynecological cohort [27], suggesting that using the PHQ-15 in a high-income 
postpartum sample does not over-identify women as high in symptom severity. 
Additional research should further explore the PHQ-15’s sensitivity and specificity 
with postpartum women. 
 There was evidence for good convergent validity of PHQ-15. Women with 
high levels of symptoms reported significantly worse overall physical health, poorer 
physical health-related QoL, and increased primary care usage. This is consistent with  
earlier studies indicating an association between the PHQ-15 and physical health-
related QoL and increased healthcare usage [10, 14, 16, 18].   A new finding was that 
high symptom severity was also associated with overall physical health ratings.  
However, we found no difference in mental health-related QoL based on symptom 
severity, which is inconsistent with previous studies [14, 16, 18]. This may be because 
mental health-related QoL (as measured by the SF-12v2) includes questions on 
current energy level, time for social activity, and feelings of calmness/peacefulness, 
all of which are likely to be affected in any women caring for a new infant. 
Exploration of the impact of women’s physical symptoms on their perception 
of their baby’s health and primary care usage showed interesting results. Although 
women generally rated their baby’s health as good (with a mean of ~9 out of 10), 
women with severe symptoms rated their baby’s physical health as poorer than 
women in all other categories and reported more primary care visits for their baby. 
This may be due to anxiety about physical symptoms and/or health generally, which 
is transferred onto the baby. These types of anxiety also can be present in individuals 
with somatic symptom disorder [28]. It would therefore be interesting to see whether 
 symptom severity on the PHQ-15 predicts the clinical diagnosis of somatic symptom 
disorder in a postpartum sample.  
It is documented that perinatal mental health problems impact both the mother 
and child [29-31]. However, to date, perinatal mental health research has focused on 
depression and anxiety [20], with somatic disorders receiving less attention. One 
explanation for this may be due to the comorbidity of depression and/or anxiety with 
somatic symptom disorder or to the classification of these three conditions in the same 
group of common mental disorders [32-34].  While these disorders share similarities, 
there are also distinctions in presentation [35] and functional outcomes [32]. 
Screening of physical symptom severity and possible somatic symptom disorder 
during the perinatal period may be important because women are more likely to be 
classified as high symptom severity than men [10, 15, 18]. Similarly, mothers may 
report more child somatic symptoms than fathers [36], and parental somatization can 
lead to the development of somatization in children [37]. The PHQ-15 potentially 
provides a useful measure of somatic symptoms in perinatal samples based on the 
current findings with postpartum women. 
The current study has a few limitations. The sample was comprised 
predominantly of white European women who were highly educated and therefore not 
representative of the general population of postpartum women. The self-reported rate 
of postpartum psychological problems in the current sample appears low at 7.3% 
compared to 15 - 20% usually reported [38].  This may have been due to the item 
wording for self-reports of psychological diagnosis or treatment pre and post-birth.  
Women were asked to indicate the presence of psychological problems ever prior to 
birth and, in a separate item, those since birth.  It may be women who reported pre-
birth psychological problems did not then also indicate a problem since birth; 
 therefore, it is difficult to ascertain the true postpartum rate in this sample.   These 
study limitations may affect the generalizability of the current findings. Prior research 
has also indicated the PHQ-15 might perform differently across ethnic groups [11], so 
future research needs to examine the validity of the PHQ-15 in different ethnic 
groups.  Finally, the current study focused on postpartum women so similar research 
is needed to examine the validity of the PHQ-15 with pregnant women. 
Conclusion 
Women often present with a range of physical symptoms during the perinatal 
period, making a brief, reliable and valid assessment tool to screen for somatic 
symptom severity useful in maternity care settings. The PHQ-15 has been widely used 
in other healthcare contexts and the current study supports the reliability and validity 
of the PHQ-15 for postpartum women. Women with severe symptoms reported poorer 
overall physical health of themselves and their baby, poorer physical health-related 
QoL, and greater use of primary care for themselves and their baby. The PHQ-15 
therefore has the potential to be a useful and valid measure of physical symptoms in 
postpartum women in high-income countries.  
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Current knowledge on the subject 
x Physical symptoms are common during pregnancy and after birth. 
x Measures of physical symptoms are needed that are reliable and valid for use 
with perinatal women. 
x The PHQ-15 is a measure of physical symptoms that has been widely used in 
other populations. 
 
 
 
 What this study adds 
x This study determines the reliability and convergent validity of the PHQ-15 
for postpartum women in high-income countries. 
x Women with a high level of symptoms (6%) reported poorer physical health 
and greater use of primary care for themselves and their babies.  
x Women with a high level of symptoms also reported poorer physical health-
related quality of life.  
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